mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte dysfunction in the development of DN are not well understood. Here we have shown that activity of mTOR complex 1 (mTORC1), a kinase that senses nutrient availability, was enhanced in the podocytes of diabetic animals. Further, podocyte-specific mTORC1 activation induced by ablation of an upstream negative regulator (PcKOTsc1) recapitulated many DN features, including podocyte loss, glomerular basement membrane thickening, mesangial expansion, and proteinuria in nondiabetic young and adult mice. Abnormal mTORC1 activation caused mislocalization of slit diaphragm proteins and induced an epithelial-mesenchymal transition-like phenotypic switch with enhanced ER stress in podocytes. Conversely, reduction of ER stress with a chemical chaperone significantly protected against both the podocyte phenotypic switch and podocyte loss in PcKOTsc1 mice. Finally, genetic reduction of podocyte-specific mTORC1 in diabetic animals suppressed the development of DN. These results indicate that mTORC1 activation in podocytes is a critical event in inducing DN and suggest that reduction of podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although podocytes have high basal levels of autophagy, high mTORC1 activity is also required for these cells to maintain their function”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ulianich, L., Garbi, C., Treglia, A. S., Punzi, D., Miele, C., Raciti, G. A., Bèguinot, F., Consiglio, E., & Jeso, B. D. (2008) · Journal of Cell Science · doi:10.1242/jcs.017202 · Cited by 114
RetractedTOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Self-citationUpstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Self-citationThe Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Self-citationKestilä, M., Lenkkeri, U., Männikkö, M., Lamerdin, J., McCready, P., Putaala, H., Ruotsalainen, V., Morita, T., Nissinen, M., Herva, R., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80057-x · Cited by 1,866
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.007 · Cited by 1,415
Susztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Podocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
Rheb Binds and Regulates the mTOR Kinase
Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005
Timmerman, L. A., Grego-Bessa, J., Raya, A., Bertrán, E., Pérez-Pomares, J. M., Díez, J., Aranda, S., Palomo, S., McCormick, F., Izpisúa-Belmonte, J. C., et al. (2004) · Genes & Development · doi:10.1101/gad.276304 · Cited by 985
Gæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Self-citationTargeted disruption of the Chop gene delays endoplasmic reticulum stress–mediated diabetes
Oyadomari, S., Koizumi, A., Takeda, K., Gotoh, T., Akira, S., Araki, E., & Mori, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14550 · Cited by 857
The podocyte’s response to injury: role in proteinuria and glomerulosclerosis
Shankland, S. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000410 · Cited by 846
Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
Nephrin is specifically located at the slit diaphragm of glomerular podocytes
Ruotsalainen, V., Ljungberg, P., Wartiovaara, J., Lenkkeri, U., Kestilä, M., Jalanko, H., Holmberg, C., & Tryggvason, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7962 · Cited by 767
The spectrum of podocytopathies: A unifying view of glomerular diseases
Wiggins, R.-C. (2007) · Kidney International · doi:10.1038/sj.ki.5002222 · Cited by 757
Self-citationTargeted disruption of the chop gene delays endoplasmic reticulum stress-mediated diabetes
Oyadomari, S., Koizumi, A., Takeda, K., Gotoh, T., Akira, S., Araki, E., & Mori, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214550 · Cited by 752
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547
Self-citationRegulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L. (2005) · Nature Neuroscience · doi:10.1038/nn1566 · Cited by 497
Self-citationAdipose-Specific Knockout of raptor Results in Lean Mice with Enhanced Mitochondrial Respiration
Polak, P., Cybulski, N., Feige, J. N., Auwerx, J., Rüegg, M. A., & Hall, M. N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.003 · Cited by 480
Self-citationInsulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., Pons, D. A., Owen, R. J., Satchell, S. C., Miles, M. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.015 · Cited by 462
The Notch pathway in podocytes plays a role in the development of glomerular disease
Niranjan, T., Bielesz, B., Gruenwald, A., Ponda, M. P., Kopp, J. B., Thomas, D. B., & Susztak, K. (2008) · Nature Medicine · doi:10.1038/nm1731 · Cited by 427
Glomerular cell number in normal subjects and in type 1 diabetic patients
Steffes, M. W., Schmidt, D., Mccrery, R., & Basgen, J. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00725.x · Cited by 408
Pathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy
Ziyadeh, F., & Wolf, G. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502370 · Cited by 383
Nephrin Expression Is Reduced in Human Diabetic Nephropathy
Doublier, S., Salvidio, G., Lupia, E., Ruotsalainen, V., Verzola, D., Deferrari, G., & Camussi, G. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1023 · Cited by 344
Tuberous Sclerosis: from Tubers to mTOR
Kwiatkowski, D. J. (2003) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2003.00012.x · Cited by 339
Self-citationLi, Y., Kang, Y. S., Dai, C., Kiss, L. P., Wen, X., & Liu, Y. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070057 · Cited by 338
Podocyte‐specific expression of cre recombinase in transgenic mice
Moeller, M. J., Sanden, S. K., Soofi, A., Wiggins, R. C., & Holzman, L. B. (2003) · genesis · doi:10.1002/gene.10164 · Cited by 333
Self-citationSiragy, H. M., Inagami, T., Ichiki, T., & Carey, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6506 · Cited by 328
Nephrin localizes to the slit pore of the glomerular epithelial cell
Holzman, L. B., ST John, P. L., Kovari, I. A., Verma, R., Holthofer, H., & Abrahamson, D. R. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00719.x · Cited by 323
Self-citationPodocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria
White, K. E., Bilous, R. W., Marshall, S. M., El Nahas, M., Remuzzi, G., Piras, G., De Cosmo, S., Viberti, G., & (ESPRIT), O. B. O. T. E. S. F. T. P. O. R. D. I. T. 1. D. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3083 · Cited by 315
Is Podocyte Injury Relevant in Diabetic Nephropathy?
Dalla Vestra, M., Masiero, A., Roiter, A. M., Saller, A., Crepaldi, G., & Fioretto, P. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1031 · Cited by 301
Podocytopenia and disease severity in IgA nephropathy
Lemley, K. V., Lafayette, R. A., Safai, M., Derby, G., Blouch, K., Squarer, A., & Myers, B. D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00269.x · Cited by 296
Increased Renal Production of Transforming Growth Factor-β1 in Patients with Type II Diabetes
Sharma, K., Ziyadeh, F. N., Alzahabi, B., McGowan, T. A., Kapoor, S., Kurnik, B. R. C., Kurnik, P. B., & Weisberg, L. S. (1997) · Diabetes · doi:10.2337/diab.46.5.854 · Cited by 274
Proteinuria and Hyperglycemia Induce Endoplasmic Reticulum Stress
Lindenmeyer, M. T., Rastaldi, M. P., Ikehata, M., Neusser, M. A., Kretzler, M., Cohen, C. D., & Schlo[Combining Diaeresis]ndorff, D. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121313 · Cited by 270
Self-citationSodium 4-Phenylbutyrate Protects against Cerebral Ischemic Injury
Qi, X., Hosoi, T., Okuma, Y., Kaneko, M., & Nomura, Y. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001339 · Cited by 263
Toyoda, M., Najafian, B., Kim, Y., Caramori, M. L., & Mauer, M. (2007) · Diabetes · doi:10.2337/db07-0019 · Cited by 257
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Hutt, D. M., Herman, D., Rodrigues, A. P. C., Noel, S., Pilewski, J. M., Matteson, J., Hoch, B., Kellner, W., Kelly, J. W., Schmidt, A., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.275 · Cited by 252
Cooper, M. E., Boner, G., Cao, Z., Kawachi, H., Bonnet, F., & Allen, T. J. (2001) · Diabetologia · doi:10.1007/s001250100546 · Cited by 249
Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats
Lloberas, N., Cruzado, J. M., Franquesa, M., Herrero-Fresneda, I., Torras, J., Alperovich, G., Rama, I., Vidal, A., & Grinyó, J. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050549 · Cited by 245
Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
Mazzucco, G., Bertani, T., Fortunato, M., Bernardi, M., Leutner, M., Boldorini, R., & Monga, G. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31988 · Cited by 238
Ma, J., Meng, Y., Kwiatkowski, D. J., Chen, X., Peng, H., Sun, Q., Zha, X., Wang, F., Wang, Y., Jing, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37964 · Cited by 231
Self-citationR., L., D., K., A., C., N., T., H., H., P., Z., N., P., D., C., & R., G. (2002) · Diabetologia · doi:10.1007/s00125-002-0946-y · Cited by 228
Barletta, G.-M., Kovari, I. A., Verma, R. K., Kerjaschki, D., & Holzman, L. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301279200 · Cited by 205
Self-citationBlockade of Vascular Endothelial Growth Factor Signaling Ameliorates Diabetic Albuminuria in Mice
Sung, S. H., Ziyadeh, F. N., Wang, A., Pyagay, P. E., Kanwar, Y. S., & Chen, S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010064 · Cited by 201
Zhong, Q., Zhou, B., Ann, D. K., Minoo, P., Liu, Y., Banfalvi, A., Krishnaveni, M. S., Dubourd, M., Demaio, L., Willis, B. C., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0347oc · Cited by 200
Podocyte biology in diabetic nephropathy
Li, J. J., Kwak, S. J., Jung, D. S., Kim, J.-J., Yoo, T.-H., Ryu, D.-R., Han, S. H., Choi, H. Y., Lee, J. E., Moon, S. J., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002384 · Cited by 192
Critical Role for Hypothalamic mTOR Activity in Energy Balance
Mori, H., Inoki, K., Münzberg, H., Opland, D., Faouzi, M., Villanueva, E. C., Ikenoue, T., Kwiatkowski, D., MacDougald, O. A., Myers, M. G., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.005 · Cited by 187
Self-citationMurea, M., Park, J.-K., Sharma, S., Kato, H., Gruenwald, A., Niranjan, T., Si, H., Thomas, D. B., Pullman, J. M., Melamed, M. L., et al. (2010) · Kidney International · doi:10.1038/ki.2010.172 · Cited by 186
Rapamycin Prevents Early Steps of the Development of Diabetic Nephropathy in Rats
Yang, Y., Wang, J., Qin, L., Shou, Z., Zhao, J., Wang, H., Chen, Y., & Chen, J. (2007) · American Journal of Nephrology · doi:10.1159/000106782 · Cited by 174
Self-citationYamaguchi, Y., Iwano, M., Suzuki, D., Nakatani, K., Kimura, K., Harada, K., Kubo, A., Akai, Y., Toyoda, M., Kanauchi, M., et al. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.05.009 · Cited by 168
Mori, H., Inoki, K., Masutani, K., Wakabayashi, Y., Komai, K., Nakagawa, R., Guan, K.-L., & Yoshimura, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.136 · Cited by 165
Self-citationGas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy
Nagai, K., Matsubara, T., Mima, A., Sumi, E., Kanamori, H., Iehara, N., Fukatsu, A., Yanagita, M., Nakano, T., Ishimoto, Y., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00433.x · Cited by 157
Current concepts in the pathogenesis of urea cycle disorders
Braissant, O. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.02.010 · Cited by 139
Regulation of Elongation Phase of mRNA Translation in Diabetic Nephropathy
Sataranatarajan, K., Mariappan, M. M., Lee, M. J., Féliers, D., Choudhury, G. G., Barnes, J. L., & Kasinath, B. S. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070412 · Cited by 125
Defective Trafficking of Nephrin Missense Mutants Rescued by a Chemical Chaperone
Liu, X., Doné, S. C., Yan, K., Kilpeläinen, P., Pikkarainen, T., & Tryggvason, K. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000129826.28932.fd · Cited by 98
ZΟ-1 Expression and Phosphorylation in Diabetic Nephropathy
Rincon-Choles, H., Vasylyeva, T. L., Pérgola, P. E., Bhandari, B., Bhandari, K., Zhang, J.-H., Wang, W., Gorin, Y. C., Barnes, J. L., & Abboud, H. E. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0355 · Cited by 93
Notch-1 activation and dendritic atrophy in prion disease
Ishikura, N., Clever, J. L., Bouzamondo-Bernstein, E., Samayoa, E., Prusiner, S. B., Huang, E. J., & DeArmond, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408612101 · Cited by 88
Epithelial-Mesenchymal Transition and Podocyte Loss in Diabetic Kidney Disease
Reidy, K. J., & Suszták, K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.07.003 · Cited by 86
Naito, T., Ma, L., Yang, H., Zuo, Y., Tang, Y., Han, J., Kon, V., & Fogo, A. B. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00503.2009 · Cited by 82
Mechanism of the process formation; podocytes vs. neurons
Kobayashi, N. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10077 · Cited by 75
Diekmann, F., & Campistol, J. M. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi336 · Cited by 75
Histone deacetylase inhibitors: A novel target of anticancer therapy (Review)
Kouraklis, G., & Theocharis, S. (2006) · Oncology Reports · doi:10.3892/or.15.2.489 · Cited by 73
Benndorf, R. A., Krebs, C. F., Hirsch-Hoffmann, B., Schwedhelm, E., Cieslar, G., Schmidt-Haupt, R., Steinmetz, O. M., Meyer‐Schwesinger, C., Thaiss, F., Haddad, M., et al. (2009) · Kidney International · doi:10.1038/ki.2009.2 · Cited by 72
Early Diabetic Nephropathy: Assessment and Potential Therapeutic Interventions
Rosenstock, J., & Raskin, P. (1986) · Diabetes Care · doi:10.2337/diacare.9.5.529 · Cited by 70
Torras, J., Herrero-Fresneda, I., Gulias, O., Flaquer, M., Vidal, A., Cruzado, J. M., Lloberas, N., Franquesa, M. {. D. }., & Grinyo, J. M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp367 · Cited by 65
Karbowniczek, M., Zitserman, D., Khabibullin, D., Hartman, T. R., Yu, J. J., Morrison, T. A., Nicolas, É., Squillace, R. M., Roegiers, F., & Henske, E. P. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40221 · Cited by 59
Increased renal production of transforming growth factor-beta1 in patients with type II diabetes
Sharma, K., Ziyadeh, F. N., Alzahabi, B., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.5.854 · Cited by 56
Franz, S., Regeniter, A., Hopfer, H., Mihatsch, M. J., & Dickenmann, M. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.004 · Cited by 52
Fountain, K. J., Kloss, A. A., Garibyan, I., Blitshteyn, B., Brezzani, A., Kyostio-Moore, S., Zuk, A., Sacchiero, R. J., & Cohen, A. S. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.003 · Cited by 12
Research works printed but not linked: 2
- Zhong, Am J Respir Cell Mol Biol.
- Kouraklis, 2006, Oncol Rep., 15, 489
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“Furthermore, recent studies have shown that either deletion or upregulation of components of the mTOR pathway, including the mTOR complexes mTORC1 and mTOR2 (210, 267), contribute to the development of diabetic nephropathy.”
BackgroundThomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Molecular mechanisms of diabetic kidney disease
Reidy, K., Kang, H. M., Hostetter, T., & Susztak, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72271 · Cited by 909
“Decreased activation of mTORC1 protected against DKD in mouse models (77, 78), but complete deletion of mTOR caused glomerular disease (78).”
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Mitochondrial dysfunction in diabetic kidney disease
Forbes, J. M., & Thorburn, D. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.9 · Cited by 634
Metadata
- Authors
- Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., Kwiatkowski, D. J., Rastaldi, M. P., Huber, T. B., Kretzler, M., Holzman, L. B., Wiggins, R. C., & Guan, K.-L.
- Affiliations
- University of Michigan (US)
- Life Sciences Institute (SG)
- University of Basel (CH)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
- University of California San Diego (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-06-01
- Volume
- 121
- Issue
- 6
- Pages
- 2181-2196
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3104745
- OpenAlex
- W2033798110
- Cited by
- 538
- References
- 77
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 23 · 2023: 36 · 2022: 33 · 2021: 22 · 2020: 48 · 2019: 43 · 2018: 39 · 2017: 39 · 2016: 39 · 2015: 35 · 2014: 44 · 2013: 45 · 2012: 36
- FWCI
- 35.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- edoc (University of Basel)
- Funders
- National Institutes of Health (5r01dk083491-09, DK083491)
- National Cancer Institute (R01CA108941)
- National Institute of General Medical Sciences (R01GM051586, GM051586)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK083491, DK-083491, R01DK124709)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Keywords
- diabetic nephropathy, mTORC1, podocytes, podocyte loss, proteinuria, glomerulosclerosis, endoplasmic reticulum stress, epithelial-mesenchymal transition, slit diaphragm proteins, TSC1, chemical chaperones, mesangial expansion, glomerular basement membrane thickening
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Regulatory-Associated Protein of mTOR, Tuberous Sclerosis Complex 1 Protein, Animals, Carrier Proteins, Cell Differentiation, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Disease Models, Animal, Endoplasmic Reticulum, Enzyme Activation, Glomerular Mesangium, Male, Membrane Proteins, Mice, Inbred C57BL, Mice, Mutant Strains, Phosphorylation, Protein Processing, Post-Translational, Proteins, Mice, Knockout, Ribosomal Protein S6 Kinases, Sirolimus, Tumor Suppressor Proteins, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, Podocytes, Glomerular Basement Membrane, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.